Naftzger J. Christopher (CIK 1496194) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-02-19). Recent activity: Buy ABUS (54,300 shares), Sell ABUS (11,333 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-19 | Arbutus Biopharma Corp (ABUS) | General Counsel and CCO | Buy | 54,300 | $0 |
| 2025-02-05 | Arbutus Biopharma Corp (ABUS) | General Counsel and CCO | Sell | 11,333 | $37,172 |
Source: SEC Form 4 filings · as of 2025-02-19